Craig-Hallum Maintains Buy on GeneDx Hldgs, Raises Price Target to $46
Portfolio Pulse from Benzinga Newsdesk
Craig-Hallum analyst Bill Bonello maintains a Buy rating on GeneDx Holdings (NASDAQ:WGS) and raises the price target from $43 to $46.
July 31, 2024 | 4:27 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Craig-Hallum analyst Bill Bonello maintains a Buy rating on GeneDx Holdings and raises the price target from $43 to $46.
The raised price target and maintained Buy rating from a reputable analyst are likely to positively impact the stock price of GeneDx Holdings in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100